Journals / Bingöl Üniversitesi Sağlık Dergisi / 2026 / Cilt: 7 Sayı: 2

Huntington’s Disease in Pregnancy: Successful Management of a Case Complicated by Severe Intrauterine Growth Restriction and Oligohydramnios

Gebelikte Huntington Hastalığı: Şiddetli İntrauterin Büyüme Geriliği ve Oligohidramniyos ile Komplike Bir Olgunun Başarılı Yönetimi

Mustafa Hakan Acer(TOKAT GAZIOSMANPASA UNIVERSITY)0000-0002-7007-545X
Mustafa Şanlı(TOKAT GAZIOSMANPASA UNIVERSITY)0009-0007-2542-5207
Hilal Özbek(TOKAT GAZİOSMANPAŞA ÜNİVERSİTESİ, SAĞLIK BİLİMLERİ FAKÜLTESİ)0000-0001-6368-2633
Pages
54–55
Publication Date
2026-08-31
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This case suggests that spinal anesthesia may be a feasible and safe alternative to general anesthesia in such patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Huntington’s disease (HD) is a rare autosomal dominant, progressive neurodegenerative disorder that may pose clinical challenges during pregnancy.
📊
Key Findings & Data:A 20-year-old primigravida with 43 Cytosine–Adenine–Guanine repeats in the Huntingtin gene was followed from the 20th gestational week.
💡
Conclusion & Impact:This case suggests that spinal anesthesia may be a feasible and safe alternative to general anesthesia in such patients.
🔬Design:Olgu Sunumu
📍Scope:Comprehensive Sample
⚙️Variables:Gebelik · Huntington Hastalığı · İntrauterin Büyüme Geriliği

Abstract

Huntington’s disease (HD) is a rare autosomal dominant, progressive neurodegenerative disorder that may pose clinical challenges during pregnancy. This case report aims to present the successful multidisciplinary management and delivery under spinal anesthesia in a pregnant woman with HD complicated by severe intrauterine growth restriction and oligohydramnios. A 20-year-old primigravida with 43 Cytosine–Adenine–Guanine repeats in the Huntingtin gene was followed from the 20th gestational week. Fetal growth restriction was detected at 26 weeks and oligohydramnios at 32 weeks. At 37 weeks, due to an Amniotic Fluid Index of 2 cm and increased umbilical artery Doppler resistance, cesarean delivery was performed under spinal anesthesia, resulting in the birth of a healthy male infant weighing 2340 g. Multidisciplinary management is essential in pregnancies complicated by HD and high-risk obstetric conditions. This case suggests that spinal anesthesia may be a feasible and safe alternative to general anesthesia in such patients.

Özet

Huntington hastalığı (HH), gebelik sırasında klinik zorluklar oluşturabilen, nadir görülen, otozomal dominant geçişli ve ilerleyici bir nörodejeneratif hastalıktır. Bu olgu sunumu, ağır intrauterin büyüme geriliği ve oligohidramniyos ile komplike olmuş Huntington hastalığı olan gebede, spinal anestezi altında gerçekleştirilen başarılı multidisipliner yönetim ve doğumu sunmayı amaçlamaktadır. Huntingtin geninde 43 Sitozin–Adenin–Guanin tekrarına sahip 20 yaşında primigravid bir olgu, gebeliğin 20. haftasından itibaren izlenmiştir. Yirmi altıncı gebelik haftasında fetal büyüme geriliği, 32. haftada ise oligohidramniyos saptanmıştır. Otuz yedinci haftada Amniyotik Sıvı İndeksi’nin 2 cm olması ve umbilikal arter Doppler direnç artışı nedeniyle spinal anestezi altında sezaryen doğum gerçekleştirilmiş ve 2340 g ağırlığında sağlıklı bir erkek bebek dünyaya gelmiştir. Huntington hastalığı ve yüksek riskli obstetrik durumlarla komplike gebeliklerde multidisipliner yönetim esastır. Bu olgu, spinal anestezinin bu hastalarda genel anesteziye uygulanabilir ve güvenli bir alternatif olabileceğini düşündürmektedir.

🔖

Cite This Article

Acer, M. H., Şanlı, M., Özbek, H. (2026). Huntington’s Disease in Pregnancy: Successful Management of a Case Complicated by Severe Intrauterine Growth Restriction and Oligohydramnios. Bingöl Üniversitesi Sağlık Dergisi, Cilt: 7 Sayı: 2, 54–55. https://doi.org/10.58605/bingolsaglik.1872764

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Piña-Aguilar RE, Simpson SA, Alshatti A, Clarke A, Craufurd D, Dorkins H, et al. 27 years of prenatal diagnosis for Huntington disease in the United Kingdom. Genet Med. 2019;21(7):1639-1643. https://doi.org/10.1038/s41436-018-0367-z.
  2. Fahy N, Rice C, Lahiri N, Desai R, Stott J. Genetic risk for Huntington disease and reproductive decision-making: a systematic review. Clin Genet. 2023;104(2):147-162. https://doi.org/10.1111/cge.14345.
  3. Olawi FM, Kierkegaard O, Zizzo AR. Pregnancy and symptomatic Huntington's disease: a case report. Int J Gynaecol Obstet. 2024;167(2):859-860. https://doi.org/10.1002/ijgo.15730.
  4. Zilberman Sharon N, Pekar-Zlotin M, Kugler N, Accart Z, Nimrodi M, Melcer Y, et al. Oligohydramnios: how severe is severe? J Matern Fetal Neonatal Med. 2022;35(25):5754-5760. https://doi.org/10.1080/14767058.2021.1892068. PMID:33645394.
  5. Nüsken E, Appel S, Saschin L, Kuiper-Makris C, Oberholz L, Schömig C, et al. Intrauterine growth restriction: need to improve diagnostic accuracy and evidence for a key role of oxidative stress in neonatal and long-term sequelae. Cells. 2024;13(6):501. https://doi.org/10.3390/cells13060501.
  6. Landau R, Sultan P. Neuraxial anesthesia and pain management for cesarean delivery. Am J Obstet Gynecol. 2026;234(1):B2-B13. https://doi.org/10.1016/j.ajog.2025.05.018.
  7. Soloniuk LJ, Jones J, Baker C, Bishawi M, Pasca I, Sinha A. Neuraxial analgesia and anesthesia for labor and cesarean delivery in a patient with juvenile Huntington disease: a case report. A A Pract. 2025;19(3). https://doi.org/10.1213/XAA.0000000000001926. Christofolini DM, Ricardo J, Ceroni M, Alves B, Bianco V, Parente Barbosa C. Preimplantation genetic diagnosis for Huntington's disease: case report and literature review. Rev Epidemiol Saúde Pública. 2024;2. https://doi.org/10.59788/resp.v2i1.63.
  8. McEnerney D, El Churafa M, Giuratrabocchetta G. Anesthetic management of a patient with Huntington's disease (HD): a case report. J Anesth Intensive Care Med. 2021;11(3):555813. https://doi.org/10.19080/JAICM.2021.11.555813.
  9. Apfelbaum JL, Hawkins JL, Agarkar M, Bucklin BA, Connis RT, Gambling DR, et al. Practice guidelines for obstetric anesthesia: an updated report by the American Society of Anesthesiologists Task Force on Obstetric Anesthesia and the Society for Obstetric Anesthesia and Perinatology. Anesthesiology. 2016;124(2):270-300.
  10. American Society of Anesthesiologists (ASA), & Society for Obstetric Anesthesia and Perinatology (SOAP). Guidelines for neuraxial analgesia or anesthesia in obstetrics. Committee of Origin: Obstetric Anesthesia. Approved by the ASA House of Delegates on October 12, 1988; last amended October 13, 2021. Available from: American Society of Anesthesiologists.
  11. Calek E, Binder J, Palmrich P, Eibensteiner F, Thajer A, Kainz T, et al. Effects of intrauterine growth restriction (IUGR) on growth and body composition compared to constitutionally small infants. Nutrients. 2023;15(19):4158. https://doi.org/10.3390/nu15194158.
  12. Bynarowicz T, Jenkins SM, Shanks AL. Oligohydramnios. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Updated 2025 May 4. Available from: NCBI Bookshelf.
  13. Ogilvie AC, Nopoulos PC, Schultz JL. Quantifying the onset of unintended weight loss in Huntington's disease: a retrospective analysis of Enroll-HD. J Huntingtons Dis. 2021;10(4):485-492. https://doi.org/10.3233/JHD-210488. PMID:34633327.
  14. Mehanna R, Jankovic J. Systemic symptoms in Huntington's disease: a comprehensive review. Mov Disord Clin Pract. 2024;11(5):453-464. https://doi.org/10.1002/mdc3.14029.
  15. American Institute of Ultrasound in Medicine (AIUM), American College of Radiology (ACR), American College of Obstetricians and Gynecologists (ACOG), Society for Maternal-Fetal Medicine (SMFM), & Society of Radiologists in Ultrasound (SRU). AIUM–ACR–ACOG–SMFM–SRU Practice Parameter for the Performance of Standard Diagnostic Obstetric Ultrasound Examinations. J Ultrasound Med. 2018;37(11):E13-E24. https://doi.org/10.1002/jum.14831. Sawant AA, Wankhede S, Thakare S, Narayan GN, Saha I, Vernekar A, et al. Maternal and perinatal outcomes in oligohydramnios: a cross-sectional analysis of pregnancies between 28 to 42 weeks of gestation. Cureus. 2025;17(2):e79232. https://doi.org/10.7759/cureus.79232. PMID:40115693.